Adcentrx Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5580 Morehouse Dr Ste 210, San Diego, Ca...Phone Number
(858) 428-9505Website
www.adcentrx.comRevenue
$7.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Adcentrx Therapeutics
Founded in 2021, headquartered in San Diego, California, Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases.Explore more
Adcentrx Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adcentrx Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Adcentrx Therapeutics had a recent Job posting/layoffs
Adcentrx Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Adcentrx Therapeutics recently announced quarterly report
Product Launch: Get notified when Adcentrx Therapeutics launches new products
Funding: Get notified immidiatlly once Adcentrx Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Adcentrx Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Adcentrx Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Adcentrx Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Adcentrx Therapeutics
Compare insights from companies similar to Adcentrx Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adcentrx Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adcentrx Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adcentrx Therapeutics.
Adcentrx Therapeutics financials insights
Gather financial insights about Adcentrx Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$50M
2023
Series A
$51M
Adcentrx Therapeutics Tech Stack
A closer look at the technologies used by Adcentrx Therapeutics
Most Recent Scoops
Person-Based
Person-Based
Open Position
Open Position
New Hire
Executive Move
Adcentrx Therapeutics News & Media
U.S. FDA Grants Orphan Drug Designation to Adcentrx Therapeutics' ADRX-0405 STEAP1 ADC for Gastric Cancer
Orphan drug designation highlights the potential for ADRX-0405 to address the high unmet need in gastric cancer SAN DIEGO, July 8, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer...Adcentrx Therapeutics Granted Fast Track Designation for ADRX-0706 Nectin-4 ADC for the Treatment of Advanced Cervical Cancer
Fast Track designation underscores the potential for ADRX-0706 to address the high unmet need in advanced cervical cancer SAN DIEGO, May 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies...Adcentrx Therapeutics to Present First Clinical Data for ADRX-0706 Nectin-4 ADC at ASCO 2025
Interim results from Phase 1a dose escalation to be presented Data provide clinical proof of concept for Adcentrx's novel technology platform; highlight unique opportunity for ADRX-0706 to address significant unmet needs for patients with limited therapeutic options SAN DIEGO, April 23,...Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025
Presentations to highlight preclinical data supporting the clear differentiation of Adcentrx's clinical-stage ADRX-0405 STEAP1 ADC and preclinical ADRX-0134 NaPi2b ADC SAN DIEGO, March 25, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adcentrx Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2021, headquartered in San Diego, California, Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases.... Read More
